mosunetuzumab,tocilizumab
roche
['toci', 'dlbcl', 'mosunetuzumab']
no severe crs were observed with mosunetuzumab monotherapy as 1l for elderly patients with dlbcl #ash22 #mosunetuzumab 
Hematologist, MD
Vall d'Hebron Hospital